Latest Interviews

All-In Summit: Gene therapy and a new era of medicine with Dr. Nicole Paulk

Dr. Nicole Paulk, Chamath, Calacanis, Friedberg

Dr. Nicole Paul's Siren Biotechnology is transitioning from stealth to clinical trials with a universal AAV platform designed to treat cancer by engineering viral logic circuits that reactivate immune surveillance against invisible tumors. Preclinical data demonstrates functional cures in human brain cancer models, positioning the company to launch its first trial in 2025 despite facing significant industry headwinds including manufacturing bottlenecks and restrictive FDA regulations. While the immediate focus remains on oncology, the technology aims to eventually enable human augmentation and longevity applications, contingent upon future regulatory shifts regarding non-disease therapeutic targets.

Universally Accessible Intelligence with Character.ai's Noam Shazeer

Noam Shazeer, Sarah Wang

Co-founder Noam Shazeer details Character.ai's vertically integrated strategy to accelerate AGI development by prioritizing generalizable dialogue models over domain-specific applications, a choice that has driven over 20 billion messages and sustained two hours of daily engagement per user. The company leverages current scaling laws to rapidly reduce training costs while projecting a model tens of IQ points smarter by year-end alongside multimodal enhancements like voice and long-term memory. Shazeer frames the technology as a pre-AGI breakthrough comparable to the Wright Brothers' first flight, predicting ubiquitous, affordable intelligence within a year as global H100 infrastructure expands, while dismissing immediate existential risks in favor of a four-month pause for safety verification.

Democratizing Design with Figma's Dylan Field

Dylan Field, David George

Figma is redefining the design industry by integrating AI agents like JamBot to transform linear workflows into non-linear exploration, effectively collapsing traditional boundaries between design and development roles. While the company acknowledges that foundational models are trending toward commoditization, it leverages its unique abstract syntax tree to position its platform as a critical bridge from "systems of record" to predictive and actionable interfaces. This strategic pivot aims to accelerate product cycles by lowering the barrier to entry for broader teams while maintaining human judgment as the essential differentiator for final production quality.

AI Copilots and the Future of Knowledge Work with Microsoft's Kevin Scott

Kevin Scott, Bob Swan

Microsoft positions artificial intelligence as a foundational platform rivaling the personal computer, driving a strategic ecosystem of partners like OpenAI, GitHub, and Meta to build unanticipated applications. The company addresses hardware scarcity and operational scaling to enable rapid deployment of models like Llama 2, aiming to trigger an industrial revolution in cognitive work by mitigating talent deficits and eliminating drudgery. Internal metrics prioritize user flow and value delivery over code volume, while leadership encourages entrepreneurs to tackle complex problems by leveraging AI as infrastructure rather than a standalone product.

AI Food Fights in the Enterprise with Databricks' Ali Ghodsi

Ali Ghodsi, Ben Horowitz

Enterprise leaders are bypassing traditional IT hierarchies to directly leverage generative AI as a competitive advantage, though adoption remains hindered by organizational friction, data privacy concerns, and the high cost of infrastructure. Organizations are navigating a strategic fork between training proprietary models for specialized tasks and relying on generalist foundations, while open-source releases accelerate innovation despite GPU scarcity. While benchmarks and ethical debates continue, the industry trajectory points toward architectural efficiency and specific vertical applications rather than immediate superintelligence threats.

Where We Go From Here with OpenAI's Mira Murati

Mira Murati, Martin Casado

Former Tesla engineer and OpenAI speaker leveraged a background in mathematics and physics to help shape the development of ChatGPT, transforming a research alignment tool into a widely adopted product through Reinforcement Learning from Human Feedback. By releasing models via public APIs, the initiative accelerated the discovery of emergent use cases while addressing critical challenges like hallucinations and the shift from finite-state programming to natural language collaboration. Looking ahead, OpenAI focuses on scaling capabilities toward artificial general intelligence and establishing dedicated teams to solve super-alignment, ensuring future systems can reliably perform human intellectual work.

Digital Biology with insitro's Daphne Koller

Daphne Koller, Vijay Pande

In-Citro, founded by Coursera co-creator Daphne Koller, is deploying a "data factory" model that uses CRISPR-edited human pluripotent stem cells to systematically generate genetic variance data for drug discovery. The company's proprietary POSH platform and multimodal biology language models analyze hundreds of millions of cells to identify disease mechanisms and predict therapeutic interventions, effectively replacing error-prone murine testing with human-derived systems. Koller aims to deliver a first tranche of medicines to patients by the end of the decade while extending this digital biology framework to address global challenges in agriculture and environmental sustainability.

Improving AI with Anthropic's Dario Amodei

Dario Amodei, Anjney Midha

Anthropic CEO Dario Amodei outlines a strategy centered on scaling laws that project model costs reaching $10 billion by 2025 while emphasizing a "talent density" hiring philosophy that prioritizes physicists and generalists over domain specialists. The organization implements Constitutional AI to replace human feedback with codified principles derived from global standards like the UN Declaration, enabling safer, self-correcting systems that balance capability growth with safety gates comparable to aviation protocols. Future product roadmaps leverage massive context windows for complex reasoning tasks, supported by mathematical projections that predict stable inference costs for the next three to four years despite increasing model size.

E146: Did the Fed break the VC model? Plus IPOs, M&A, revaluing unicorns & more

Chamath, Calacanis, Friedberg

Chamath Palihapitiya and David Sacks led the 2023 All In Summit, discussing personal health optimization, the evolving US political landscape, and a detailed analysis of the recovering IPO market amidst macroeconomic headwinds. The event featured critical assessments of recent venture exits, warnings about "zombie unicorns" facing equity dilution, and significant scientific breakthroughs in autoimmune therapies using inverse vaccines. With a focus on avoiding geopolitical catastrophe and navigating capital scarcity, the summit concluded that market forces will likely impose fiscal restraint rather than legislative action.

All-In Summit: Nuclear fusion and the potential for energy abundance

Robert Mumgaard, David Kirtley, Bob Momgard, Chamath, Calacanis, Friedberg

Leading fusion startups Commonwealth Fusion Systems and Helion Energy are racing to validate their distinct technologies, with targets to deliver net energy gain by 2026 and commercial power by 2028 respectively. These ventures leverage over $6 billion in private capital and advanced engineering to aim for electricity costs under one cent per kilowatt-hour, addressing the projected fivefold increase in global energy demand. Industry consensus indicates that no single architecture will dominate the coming energy transition, necessitating a portfolio of competing solutions to provide the thousands of gigawatts required for decarbonization and electrification.

All-In Summit: In conversation with Brian Armstrong

Brian Armstrong, Sam Bankman-Fried, Chamath, Calacanis, Friedberg

Coinbase CEO Brian Armstrong advocates for a regulatory framework that treats centralized exchanges like traditional financial institutions while exempting decentralized protocols, arguing that the current SEC enforcement under Gary Gensler has become a political weaponization that stifles innovation. He details the company's legal challenges against the agency, emphasizing recent court victories that clarified asset classifications and rejecting settlement offers that would have forced the delisting of all assets except Bitcoin and Ethereum. Looking forward, Armstrong calls for election-year reforms to accredited investor rules and the expansion of Layer 2 solutions to overcome user experience barriers, aiming to shift the industry focus from niche speculation to mass-market practical applications.

40 AI Founders Discuss Current Artificial Intelligence Technology

The panel explored generative AI's expanding capabilities in creative storytelling, rapid software development, and indistinguishable voice synthesis while highlighting persistent operational hurdles like hallucinations and the difficulty of balancing deterministic logic with probabilistic outputs. Speakers detailed the necessity for continuous model fine-tuning across dynamic sectors like fashion and the critical reliance on human-in-the-loop verification to manage reliability risks in high-stakes fields such as healthcare. Ultimately, the discussion framed current AI technologies as tools designed to augment human judgment rather than replace it, emphasizing that long-term viability depends on building user trust through transparent accuracy metrics and nuanced oversight.

Nick Cannon: How I ACCIDENTALLY Built A $1.3 Billion Business!

Nick Cannon, Jamie Foxx, Will Smith, will.i.am, Stephen

Nick Cannon has transformed his early career breakthroughs under mentors like Will Smith and Jamie Foxx into a billion-dollar entertainment conglomerate centered on the *Wild 'N Out* franchise and his headphone brand. Following a life-threatening battle with kidney failure and the loss of his son, Cannon pivoted his business philosophy to prioritize IP ownership, ethical revenue, and the stewardship of young talent over transactional success. As he prepares to hand over the hosting duties of his flagship show after its 21st season, he continues to operate as an incubator for the next generation of artists while aiming to leave a legacy defined by compassion and humor.

All-In Summit: In conversation with Graham Allison

Graham Allison, Chamath, Calacanis, Friedberg

In his discussion of *Destined for War*, former U.S. Assistant Secretary of Defense Graham Allison warns that the structural dynamics of a rising China displacing a ruling United States create a historically high probability of conflict, with a roughly 10% chance of war occurring within the next four years. Allison attributes this tension to historical precedents, U.S. policy failures regarding China's integration into the global order, and the strategic misalignment over spheres of influence, particularly regarding Taiwan. He concludes that avoiding a catastrophic "Thucydides Trap" requires policymakers to exercise strategic imagination by explicitly weighing incentives to compete against those for cooperation, rather than relying on default posturing or bureaucratic inertia.

All-In Summit: In conversation with Gwyneth Paltrow

Gwyneth Paltrow, David Sacks, Chamath, Calacanis, Friedberg

In a candid discussion with the *All-In* hosts, Gwyneth Paltrow detailed her transition from acting to founding Goop, attributing her entrepreneurial drive to a desire for creative autonomy and her evolution into a wellness pioneer. She critically examined Hollywood's current landscape, addressing the tensions surrounding AI technology, the collapse of traditional cinema models, and the systemic inefficiencies fueling industry strikes. The conversation also covered her philosophical stance on cancel culture, her reflections on aging, and the operational lessons she learned while scaling a female-led global brand.